Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Con: Patients With Acute‐on‐Chronic Liver Failure Should Not Receive Priority on the Waiting List
Nadim Mahmud, K. Rajender Reddy – 19 May 2022
Posttransplant complications in the setting of acute‐on‐chronic liver failure and considerations regarding immunosuppression
M. Valerie Lin, Fredric D. Gordon – 19 May 2022
Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Become a Member
Joining AASLD means becoming a part of the premier organization committed to preventing and curing liver disease.
Journals
Read the latest article abstracts, practice guidelines, and more from HEPATOLOGY, Liver Transplantation, Clinical Liver Disease and Hepatology Communications.
Membership Benefits
Whether you are a hepatologist, researcher, physician, student, trainee, or allied-health practitioner, AASLD serves you at every stage of your career.
Strategic Plan
With continuous progress and measurement to ensure we are meeting our goals, AASLD is forging a new path to support the hepatology community in advancing the science of liver disease.
PP2 protects from keratin mutation–associated liver injury and filament disruption via SRC kinase inhibition in male but not female mice
Pei Li, Dhiman Maitra, Ning Kuo, Raymond Kwan, Yang Song, Weiliang Tang, Lu Chen, Qing Xie, Li Liu, M. Bishr Omary – 18 May 2022
Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor
Wenjing Xu, Changting Cui, Chunmei Cui, Zhenzhen Chen, Haizeng Zhang, Qinghua Cui, Guoheng Xu, Jianglin Fan, Yu Han, Liangjie Tang, Giovanni Targher, Christopher D. Byrne, Ming‐Hua Zheng, Liming Yang, Jun Cai, Bin Geng – 18 May 2022